Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul 19;166(2):261-72.
doi: 10.1083/jcb.200401034.

Novel signaling pathways mediating reciprocal control of keratinocyte migration and wound epithelialization through M3 and M4 muscarinic receptors

Affiliations

Novel signaling pathways mediating reciprocal control of keratinocyte migration and wound epithelialization through M3 and M4 muscarinic receptors

Alex I Chernyavsky et al. J Cell Biol. .

Abstract

To test the hypothesis that keratinocyte (KC) migration is modulated by distinct muscarinic acetylcholine (ACh) receptor subtypes, we inactivated signaling through specific receptors in in vitro and in vivo models of reepithelialization by subtype-selective antagonists, small interfering RNA, and gene knockout in mice. KC migration and wound reepithelialization were facilitated by M4 and inhibited by M3. Additional studies showed that M4 increases expression of "migratory" integrins alpha5beta1, alphaVbeta5, and alphaVbeta6, whereas M3 up-regulates "sedentary" integrins alpha2beta1 and alpha3beta1. Inhibition of migration by M3 was mediated through Ca2+-dependent guanylyl cyclase-cyclic GMP-protein kinase G signaling pathway. The M4 effects resulted from inhibition of the inhibitory pathway involving the adenylyl cyclase-cyclic AMP-protein kinase A pathway. Both signaling pathways intersected at Rho, indicating that Rho kinase provides a common effector for M3 and M4 regulation of cell migration. These findings offer novel insights into the mechanisms of ACh-mediated modulation of KC migration and wound reepithelialization, and may aid the development of novel methods to promote wound healing.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
In vitro experiments with anti-mAChR siRNA. (A) Representative results of Western blot analysis of the effects of siRNA-M3 and siRNA-M4 on M3 and M4 mAChR expression in human KCs transfected with anti-mAChR siRNAs or negative control (NC) siRNA. On the third day after transfection, the cellular proteins were analyzed by Western blotting. The results were compared with those obtained with control (C) KCs exposed to TransIT-TKO (Mirus Corp.) transfection reagent mixed in Opti-MEM medium (GIBCO BRL) alone. The numbers underneath the bands are ratios of the densitometry value of each mAChR receptor to that of β-actin compared with the values obtained in control KCs (taken as 1). (B) IF analysis of the effects of anti-M3 and anti-M4 siRNAs on the expression of the M3 and M4 mAChR subtypes on the cell membrane of human KCs. The cells were cultured and treated with the siRNA-M3 (black bars), siRNA-M4 (white bars), or negative control siRNA (not depicted) as described in A, fixed to avoid cell membrane permeabilization, and stained with anti-M3 or anti-M4 antibodies. (C) Dose-dependent effects of receptor-selective siRNA on KC migration. Second passage human KCs were loaded into AGKOS plates, transfected with 1.2, 12, or 120 nM of negative control M3 or M4 siRNA, or exposed to TransIT-TKO transfection reagent mixed in Opti-MEM medium alone (control), and then used in AGKOS assay. (D) Opposing alterations in KC crawling locomotion due to M3 and M4 receptor gene silencing. (B–D) Asterisk indicates significant (P < 0.05) differences from untreated control. NC, negative control siRNA.
Figure 2.
Figure 2.
Effects of mAChR gene KO on crawling locomotion of murine KCs. (A) The representative images of wound tissue of WT and mAChR KO mice harvested on the third and fifth day after wounding. The edge of the full thickness wound extending from the epidermis down to the dermis is depicted by arrowheads. The direction of forward movement of the epithelial tongue from the excision site (arrow) is indicated with a dotted line with an arrowhead. Bar, 150 μm. Insets show immunolocalization of M3 and M4 on the epithelial tongues of M4 −/− and M3 −/− mice, respectively, on the fifth day after wounding. Bar, 20 μm. (B) Alterations in epithelialization rate of skin wounds in M3 −/− and M4 −/− mice. The data are means ± SD of the rate of epithelialization computed in six M3 −/− and M4 −/− mice compared with that determined in six WT animals, taken as 100%. *, significant (P < 0.05) differences from the epithelization rate in WT mice. #, P = 0.05. (C) Representative images of hair follicles in the skin of 1-d-old WT and mAChR KO mice. An apparent stage of morphogenesis is shown as numbers underneath each hair follicle. Hematoxylin and eosin staining of cryostat sections of the longitudinal sections harvested from the upper back skin. Bar, 50 μm. (D) Quantitative morphometric analysis of hair follicle development in mAChR KO mice. The percentage of hair follicles in each stage of morphogenesis (x axis) was determined in 1-d-old WT, M3 −/−, and M4 −/− mice. (E) Alterations of migration rate of KCs from M3 −/− and M4 −/− mice in AGKOS plates. The results are means ± SD of the migration distance of intact WT KCs (taken as 100%). *, significant (P < 0.05) differences from the migration distance of WT KCs; #, significant (P < 0.05) differences from the migration distances of nontreated KCs in each subgroup.
Figure 3.
Figure 3.
Effects of the mAChR signaling modifiers on migration of human KCs. The migration assays of intact or siRNA-M3– or siRNA-M4–transfected KCs were performed in AGKOS plates. The cells were exposed to 1 μM thapsigargin (TG), 10 μM LY-83,583 (LY), 1 mM SQ 22536 (SQ), 50 μM Sp-8-Br-cAMPS (Sp), 5 μM 8-pCPT-cGMP (8p),1 μM Rp-8-pCPT-cGMPS (Rp), 25 nM KT5720 (KT), 10 μg/ml C3 exoenzyme (C3), 5 μM Y-27632 (Y), or 10 nM MT3 dissolved in KGM. Some cells were pretreated for 30 min with thapsigargin, Rp-8-pCPT-cGMPS, or KT5720 before exposing them to a second test agent versus no additional (NA) treatment. The results are expressed as means ± SD of nontreated control, taken as 100%. *, significant (P < 0.05) differences from control. Significant differences between specific experimental conditions are indicated in the graph with square brackets with arrows.
Figure 4.
Figure 4.
Muscarinic effects on integrin expression in human KCs. Relative amounts of α2, α3, α5, αV, and β5 integrins were analyzed by Western blotting of total protein isolated from human KCs 72 h after transfection with siRNA-M3, siRNA-M4, or negative control siRNA (siRNA-NC), and from control KCs treated with TransIT-TKO transfection reagent mixed in Opti-MEM medium alone (control). Changes in the expression of integrins in human cultured KCs treated with mAChR signaling modifiers were similarly analyzed after incubation for 6 h or 10 d in the absence (control) or presence of 1 μM Rp-8-pCPT-cGMPS (Rp), 25 nM KT5720 (KT) or 10 nM MT3, or a combinations of these agents shown in the table. The images show typical bands appearing at the expected molecular weights (MW). *, significant (P < 0.05) differences from control.
Figure 5.
Figure 5.
Role of integrins in mediating effects of M3 and M4 mAChRs on KC migration in vivo and in vitro. (A) Western blotting analysis of integrin gene expression. Equal samples of normal (N), i.e., intact, and wound (W) tissues were harvested from two wounds inflicted in six mice of each subgroup 24 h after wounding. Monolayers of murine KCs were established from the skin of neonatal WT and M3 −/− and M4 −/− mutant mice, and grown to ∼70% confluence in KGM. The results are expressed as ratios of the densitometry value of each integrin to that of β-actin in the same lane, compared with the values obtained in either intact skin or KCs grown from WT mice (taken as 1). (B) Semiquantitative IF analysis of KC integrin expression in the skin of WT and M3 −/− and M4 −/− mutant mice. Cryostat sections of intact and wounded skin from killed mice were stained with the antibodies targeting integrins indicated on the x axis. Fluorescence intensities of normal (intact) and wounded skin in the KO mice are expressed relative to levels determined in the intact and wounded skin, respectively, of WT mice (taken as 100%). Data are means ± SD from experiments performed with the tissue from two wounds in each of six mice in each subgroup. All changes are statistically significant (P < 0.05). (C) Immunolocalization of integrin receptors in KCs comprising the epithelialization tongue of WT mice on the third day after wounding. Bar, 25 μm. (D) Effects of the mAChR gene null mutation on the ability of murine KCs to migrate over ECM proteins. The migration distance was measured using a scratch assay. The M3 −/− and M4 −/− versus WT (control) KCs were freshly seeded in the culture dishes either uncoated (uc) or coated with fibronectin (fn), vitronectin (vn), laminin (lm), collagen I (cI) or IV (cIV), and the formed monolayers were wounded with a 100-μl pipette tip. The amount of migration was quantitated, and the results were expressed relative to migration distance of WT KCs (taken as 100%). (E) Effects of antiintegrin antibodies on migration distance of mAChR KO and WT KCs. The migration distance was measured using a scratch assay. The M3 −/− and M4 −/− KCs were grown to confluence in uncoated culture dishes, and the monolayers were wounded with a 100-μl pipette tip and incubated with (experiment) or without (control) antibodies targeting integrins identified on the x axis. The amount of migration was quantitated, and the results were expressed relative to migration distance of control KCs (taken as 100%). (A, D, and E) Asterisks indicate significant (P < 0.05) differences from control.
Figure 6.
Figure 6.
Hypothetical scheme of the signaling mechanisms linking M3 and M4 to regulation KC motility and integrin expression. The signaling cascades originating at M3 and M4 include distinct stimulatory (→) and inhibitory (•••) steps and converge at the common effector pathway involving Rho proteins.

References

    1. Alfonzo, M.J., I.L. de Becemberg, S.S. de Villaroel, V.N. de Herrera, A.J. Misle, and R.G. de Alfonzo. 1998. Two opposite signal transducing mechanisms regulate a G-protein-coupled guanylyl cyclase. Arch. Biochem. Biophys. 350:19–25. - PubMed
    1. Arai, H., C.L. Tsou, and I.F. Charo. 1997. Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by βγ dimers released by activation of Gαi-coupled receptors. Proc. Natl. Acad. Sci. USA. 94:14495–14499. - PMC - PubMed
    1. Arredondo, J., V.T. Nguyen, A.I. Chernyavsky, D. Bercovich, A. Orr-Urtreger, W. Kummer, K. Lips, D.E. Vetter, and S.A. Grando. 2002. Central role of α7 nicotinic receptor in differentiation of the stratified squamous epithelium. J. Cell Biol. 159:325–336. - PMC - PubMed
    1. Botchkarev, V.A., N.V. Botchkarev, K.M. Albers, C. van der Veen, G.R. Lewin, and R. Paus. 1998. Neurotrophin-3 involvement in the regulation of hair follicle morphogenesis. J. Invest. Dermatol. 111:279–285. - PubMed
    1. Butt, E., M. Eigenthaler, and H.G. Genieser. 1994. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur. J. Pharmacol. 269:265–268. - PubMed

Publication types

LinkOut - more resources